News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.
Contact UsAll Articles
-
A mission to improve patient access: Tanner Pharma Group
Tanner Pharma Group was founded two decades ago specifically to improve patient access to life-saving medicines. Tanner operates around the world, working with manufacturers, non-profit organizations, physicians and health authorities to get treatments to patients on the ground while navigating issues that include regulations, languages, supplies, and logistics. In this article Steve Scalia, president, shares…
Read More -
Economic Development Partnership of North Carolina Recognizes Tanner Pharma as “Top Global Reach Exporter”
Originally published on the EDPNC website. Earlier today, North Carolina Governor Roy Cooper announced 8 winners of the 2021 Governor’s Export Awards, ranging from a sportfishing boat manufacturer to a Telecommunications equipment supplier. “North Carolinians make outstanding, high-quality products that are sold in markets around the world,” said Governor Roy Cooper. “The companies we honor…
Read More -
Tanner Pharma Group and REV Pharma Donate Wound Care Treatment to SOS EB Kids to Improve the Lives of Children with Epidermolysis Bullosa
Brasília, DF, Brazil January 25, 2022 – SOS EB Kids, a nonprofit organization whose mission is to improve the quality of life of Brazilian children living with Epidermolysis Bullosa (EB), recently received a donation of Curefini Ointment from Tanner Pharma Group (“Tanner”) and REV Pharma Corp. (“REV”). EB is a rare and serious genetic illness…
Read More -
Solving the Industry’s Most Challenging Sourcing and Supply Needs
Originally featured in the CTS Clinical Trial Supply Handbook 2022. Whether it’s procuring comparator drugs, packaging, labelling and kitting, or distributing drug products and supplies to hundreds of clinical trial sites, you need a smart, agile partner with the ability to manage complex supply chains and global logistics. By choosing Tanner Pharma, you gain: Access…
Read More -
The Value of Dogged Determination
How companies can strengthen their supply chains when presented with unprecedented challenges Originally published on The Medicine Maker. Our industry’s supply chains have been subjected to unprecedented headwinds in the last two years. Drug/vaccine developers and manufacturers must constantly be alert to potential disruptions and proactively find ways to prevent, or at least minimize, delays…
Read More -
Tanner Pharma Group Named One of the “Best Places to Work”
Charlotte, NC – Tanner Pharma Group is honored to be recognized by the Charlotte Business Journal as one of the “Best Places to Work.” The culture of Tanner is built from the passion of its team members and their willingness and dedication to creating possibilities and securing positive outcomes to improve lives around the world.…
Read More -
Oneness Biotech and Tanner Pharma Group Initiate Early Access Program for Fespixon®, a Novel Macrophage-regulating New Therapy for the Treatment of Diabetic Foot Ulcers
15th November 2021 Oneness Biotech (4743.TT), a leading biotech company listed on the Taipei stock exchange, and Tanner Pharma UK Limited (“Tanner Pharma”), a specialist pharmaceutical services provider of medicine access solutions, announced the initiation of an early access program for Fespixon in Europe, the UK, Russia, Latin America, the Middle East and North Africa…
Read More -
Product Expansion in Emerging Markets: Questions You Should Be Asking
Pharmaceutical product registration and commercialization can be a complex process. And when it comes to product expansion in emerging markets, the waters can become even more cloudy. With almost two decades of experience, the TannerLAC team has seen it all and understands how to navigate the often challenging and rigorous requirements. Different countries have different…
Read More -
A Resource for Accessing Rare Disease Therapies Globally
As featured on Patient Worthy: Rare Patient News Access Opportunities for Rare Disease Patients At present, there are around 7,000 identified rare diseases, with only 5% having treatments. That leaves more than 95% of rare disease patients with little to no options, especially those in low-resource countries where access can prove even more challenging. Often, even…
Read More -
Hispanic Heritage Month
Hispanic Heritage Month runs from September 15 – October 15 and recognizes the cultures, histories, achievements and contributions of Hispanic Americans. Unlike many monthly observances, Hispanic Heritage Month begins in the middle rather than the start of September. This is because it coincides with the national independence days of several Latin American countries including Costa…
Read More -
TannerCares Launches First Volunteer Event with Baby Bundles
TannerCares is the philanthropic commitment of our company and was set-up as a means to support charities within the healthcare space, the causes of our partners, and local events that mean something to our team members through the giving of time and financial resources. The Tanner Volunteer Program is a component of this initiative and…
Read More -
Tanner Pharma Group Announces New EVP of Technical Operations
CHARLOTTE, N.C.–(BUSINESS WIRE)–Tanner Pharma Group (“Tanner”), a global pharma-solutions provider, today announced the hiring of Lee Holmes as Executive Vice President of Technical Operations. Having worked in the healthcare industry for over 25 years across a wide range of global leadership roles, Lee brings with him a wealth of industry knowledge and experience, offering particularly…
Read More -
Alimera Sciences and Tanner Pharma Group Initiate Global Named Patient Program for ILUVIEN®
July 30, 2021 08:00 AM Irish Standard Time DUBLIN, Ireland and CHARLOTTE, USA – Alimera Sciences Europe Limited (“Alimera”), a wholly owned subsidiary of Alimera Sciences, Inc., and Tanner Pharma UK Limited (“Tanner”) announced today the initiation of a global Named Patient Program for ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg for the treatment of…
Read More -
Tanner Pharma Group Gives Donation to Benefit MAP International’s Bringing Children Health Program
Brunswick, GA – MAP International, a nonprofit health organization whose mission is to provide medicines and health supplies to those in need around the world so that they might experience life to the fullest, recently received a generous donation from Tanner Pharma Group. The donation of over 18,000 units of pharmaceutical products and cash, valued…
Read More -
Building a Culture of Well-Being: A Partnership Between Tanner Pharma Group and Red Dot 365
At Tanner Pharma, our purpose revolves around people. This focus not only includes the patients, physicians, pharma companies and NGO’s we serve and partner with, but our outstanding team members who help us make a difference and positively impact lives around the world. With that in mind, we are continuously seeking ways to support our…
Read More -
Evolving for the Greater Good in the COVID-19 Era
At Tanner, we think of giving not only as a duty but as a privilege. A critical part of our success is that the mission and culture of Tanner Pharma is embodied in each member of our team. Whether it’s through the global programs we develop and manage for our clients, or the fundraising we…
Read More -
From Patient Access to Real World Data – Early Access Programs Offer Compelling Results
What is an EAP? Early Access Programs (EAPs), also referred to as Compassionate Use, Managed Access Programs or Expanded Access Programs, are a pathway by which pharma and biopharmaceutical companies provide investigational new drugs (INDs) to patients with serious conditions. Often, patients have exhausted their approved therapies and cannot participate in a clinical trial. These…
Read More -
Again Life Italia Announces Partnership with Tanner Pharma Group
CHARLOTTE, N.C., May 27, 2021 — Again Life Italia S.r.l. (“ALI”), a pharmaceutical biotechnology company headquartered in Italy, and TannerLAC UK Limited (“TannerLAC”), a wholly owned subsidiary of Tanner Pharma Group and company leader in the Latin American market, announced today the signing of a business partnership agreement for Latin America. With a presence in…
Read More